Figure 7From: A randomized, double-blind comparison of OROS®hydromorphone and controlled-release morphine for the control of chronic cancer pain Patient (A) and investigator (B) global evaluations of treatment effectiveness at the end of the sustained-release (SR) phase. CR, controlled-release. Back to article page